ARTICLE | Clinical News

Cel-Sci preclinical data

February 6, 1995 8:00 AM UTC

CELI (Alexandria, Va.) reported that low doses of Multikine boosted levels of killer T cells and natural killer cells to a level higher than those produced by interleukin-2 or interferon gamma.

The data, collected in human blood and in mice, were presented at the Third International Congress on Biological Response Modifiers in Cancun, Mexico. A trial in 30 patients with head and neck cancer is planned for this year. ...